as on March 14, 2026 at 6:59 am IST
Day's Low
Day's High
2.44%
Downside
7.32%
Upside
52 Week's Low
52 Week's High
56.71%
Downside
59.50%
Upside
Check Coherus Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$253.1M
EPS (TTM)
-0.21
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.76%
PE Ratio (TTM)
-5.58
Industry PE ratio
-3.3382638888888887
PEG Ratio
0EBITDA
-172.5M
Revenue (TTM)
42.2M
Profit Margin
398.42%
Return On Equity TTM
33.11%
Track how Coherus Biosciences Inc P/E has moved over time to understand its valuation trends.
Coherus Biosciences Inc in the last 5 years
Lowest (-25.72x)
September 30, 2021
Today (-5.58x)
March 14, 2026
Industry (-3.34x)
March 14, 2026
Highest (141.62x)
June 30, 2021
Today’s Price to Earnings Ratio: -5.58x
Compare market cap, revenue, PE, and other key metrics of Coherus Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $253.1M | -89.97% | -5.58 | 398.42% | |
| BUY | $42.1B | 120.4% | 136.74 | 8.45% | |
| BUY | $121.4B | 118.98% | 31.23 | 32.94% | |
| NA | $33.0B | NA | 115.04 | 5.37% | |
| BUY | $78.9B | 58.18% | 17.99 | 31.41% |
The Coherus Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Coherus Biosciences Inc investment value today
Current value as on today
₹1,84,570
Returns
₹84,570
(+84.57%)
Returns from Coherus Biosciences Inc Stock
₹78,261 (+78.26%)
Dollar Returns*
₹6,309 (+6.31%)
Based on 16 analysts
81.25%
Buy
18.75%
Hold
0.00%
Sell
Based on 16 analysts, 81.25% of analysts recommend a 'BUY' rating for Coherus Biosciences Inc. Average target price of $6.75
Get share price movements and forecasts by analysts on Coherus Biosciences Inc.
What analysts predicted
75.7%UPSIDE
Target Price
$6.75
Current Price
$1.64
Analyzed by
16 Analysts
Target
$6.75
Coherus Biosciences Inc target price $6.75, a slight upside of 75.7% compared to current price of $1.64. According to 16 analysts rating.
Search interest for Coherus Biosciences Inc Stock has decreased by -71% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 4 quarters, 7.59M → 12.74M (in $), with an average increase of 15.5% per quarter
Best in 1 Year
![]()
In the last 1 year, CHRS has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 67.5% return, outperforming this stock by 141.8%
Profit Down
![]()
Netprofit is down for the last 3 quarters, 297.76M → -375.95M (in $), with an average decrease of 535.0% per quarter
Price Dip
![]()
In the last 7 days, CHRS stock has moved down by -10.4%
| Organisation | Coherus Biosciences Inc |
| Headquarters | 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065 |
| Industry | Health Technology |
| CEO | Mr. Dennis M. Lanfear |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Theresa M. Lavallee Ph.D. | Chief Development Officer & Chairman of Scientific Advisory Board |
Dr. Rosh Dias M.D., MRCP | Chief Medical Officer |
Mr. Sameer Goregaoker | Chief Commercial Officer |
Mr. Bryan J. McMichael | Chief Financial Officer |
Ms. Carrie Graham | Vice President of Investor Relations & Advocacy |
Mr. Andy Rittenberg | Chief Legal Officer |
Mr. Michael Chen | Senior Vice President of Commercial Analytics & Trade |
Mr. Dennis M. Lanfear | Chairman, President & CEO |
Ms. Rebecca Sunshine | Chief Human Resources Officer |
Mr. Arvind Sood | Chief Strategy & Corporate Affairs Officer |
Coherus Biosciences Inc share price today is $1.64 as on at the close of the market. Coherus Biosciences Inc share today touched a day high of $1.76 and a low of $1.6.
Coherus Biosciences Inc share touched a 52 week high of $2.62 on and a 52 week low of $0.71 on . Coherus Biosciences Inc stock price today i.e. is closed at $1.64,which is 37.30% down from its 52 week high and 130.99% up from its 52 week low.
Coherus Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Coherus Biosciences Inc (CHRS) shares with as little as ₹92.409 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹924.09 in Coherus Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Coherus Biosciences Inc share’s latest price of $1.64 as on March 14, 2026 at 1:29 am IST, you will get 6.0976 shares of Coherus Biosciences Inc. Learn more about
fractional shares .
Coherus Biosciences Inc stock has given -89.97% share price returns and 26.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?